ZANUBRUTINIB for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ZANUBRUTINIB was used for Diffuse large b-cell lymphoma refractory.
Most Reported Side Effects for ZANUBRUTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 376 | 13.4% | 43 | 116 |
| Disease progression | 224 | 8.0% | 41 | 26 |
| Contusion | 165 | 5.9% | 3 | 23 |
| Myelosuppression | 147 | 5.3% | 4 | 68 |
| Fatigue | 146 | 5.2% | 13 | 34 |
| Rash | 134 | 4.8% | 5 | 20 |
| Death | 120 | 4.3% | 120 | 15 |
| White blood cell count decreased | 119 | 4.3% | 9 | 37 |
| Platelet count decreased | 112 | 4.0% | 9 | 37 |
| Anaemia | 102 | 3.7% | 11 | 20 |
| Diarrhoea | 101 | 3.6% | 12 | 22 |
| Pneumonia | 100 | 3.6% | 21 | 55 |
| Covid-19 | 89 | 3.2% | 17 | 40 |
| Drug ineffective | 87 | 3.1% | 24 | 27 |
| Asthenia | 81 | 2.9% | 10 | 30 |
Other Indications for ZANUBRUTINIB
Chronic lymphocytic leukaemia (726)
Waldenstrom's macroglobulinaemia (429)
Product used for unknown indication (418)
Mantle cell lymphoma (329)
Diffuse large b-cell lymphoma (251)
Marginal zone lymphoma (97)
B-cell small lymphocytic lymphoma (74)
B-cell lymphoma (73)
Follicular lymphoma (68)
Lymphoma (64)
Other Drugs Used for Diffuse large b-cell lymphoma refractory
RITUXIMAB (667)
EPCORITAMAB-BYSP (353)
AXICABTAGENE CILOLEUCEL (336)
BENDAMUSTINE (283)
CYCLOPHOSPHAMIDE (226)
POLATUZUMAB VEDOTIN (223)
ETOPOSIDE (165)
POLATUZUMAB VEDOTIN-PIIQ (158)
GEMCITABINE (147)
LENALIDOMIDE (143)